Here’s a question that shouldn’t require an ounce of political courage to answer: Should the federal government use your tax dollars to fund irreversible medical procedures on children too young to vote, drive, or sign a contract? For years, a radical ideology wormed its way into pediatric medicine. It convinced hospitals and insurers that confused adolescents needed puberty blockers, cross-sex hormones, and even surgeries — all on your dime. Parents who pushed back got labeled bigots. Doctors who raised red flags were shoved aside.

But the ground has been shifting. Sweden, Finland, Denmark, and England have all slammed the brakes on pediatric gender interventions after independent reviews exposed the evidence base as dangerously thin. These aren’t right-wing governments. They’re socialized healthcare systems with zero partisan motivation. And now, the United States federal government has finally caught up.

From The Post Millennial:

The Trump administration on Tuesday revealed that it is ending the use of federal Medicaid and Children’s Health Insurance Program (CHIP) funding for sex-change surgeries and procedures for minors. The final rule unveiled by the Centers for Medicare and Medicaid Services (CMS) will go into effect on October 13.

Good. It’s about time.

A long-overdue reckoning

The CMS rule bars Medicaid dollars from covering what the agency terms “sex-rejecting procedures” for anyone under 18. CHIP plans are prohibited from funding the same interventions for anyone under 19. Children currently receiving cross-sex hormone therapy get a six-month tapering period to transition off treatment safely. And — this matters — mental health services remain fully available. Nobody is ripping away counseling or psychiatric support. This rule targets irreversible physical interventions. Period.

President Trump was characteristically blunt about it. “We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies,” he wrote on social media.

HHS Secretary Robert F. Kennedy Jr. grounded the decision in something the opposition conveniently ignores — actual evidence. “These interventions carry serious risks and can cause irreversible harm,” he said. “The federal government will no longer use Medicaid and CHIP dollars to fund procedures that fail to meet the evidentiary standard our children deserve.”

That phrase — evidentiary standard — deserves your attention. This isn’t culture war theatrics. It’s a government finally demanding receipts before it bankrolls experimental medicine on minors.

The science the left would rather you not notice

CMS Administrator Dr. Mehmet Oz leaned into language the progressive establishment has long claimed as exclusively theirs: “We’re following the science, saving taxpayer dollars, and, most importantly, protecting children from potentially irreversible harm so they can truly flourish.”

Right on cue, the advocacy industrial complex erupted. The Human Rights Campaign accused the administration of “terrorizing trans youth.” The Trevor Project called it a “dangerous restriction on doctor-prescribed health care.” The National Women’s Law Center warned of “jeopardizing vital health care.” Same playbook, different Tuesday.

But here’s what those organizations won’t mention. A 2024 study published in JAMA Network Open found that fewer than one percent of minors had received any form of surgical gender-affirming care. Among those who received breast reductions, 97 percent were biological males treated for gynecomastia — not transgender patients. So the apocalyptic rhetoric doesn’t square with the actual numbers. This rule is a measured, common-sense guardrail. The hysterical response tells you more about the activists’ political agenda than about any genuine threat to patient care.

And then there’s the inconvenient international context. England’s landmark Cass Review found pediatric gender medicine built on remarkably flimsy foundations. Progressive Europe agreeing with Donald Trump — sometimes reality writes its own punchlines.

Hospitals are already getting the message

The rule also formalizes a correction already underway. As Trump pointed out, “dozens of US hospitals have already ended this so-called ‘gender-affirming care.'” The administration used the lever of federal funding — not sweeping mandates — to accelerate what the medical community was slowly acknowledging on its own. That’s smart governance. Federalism with teeth.

Trump, never one to miss a political opening, connected the dots to November: “While the Democrat Party wants your kids to be able to chop off their reproductive organs before they are old enough to vote… the Republican Party says that is ABSURD, and we will protect America’s children.”

Lawsuits are coming. Breathless cable news segments are inevitable. Accusations of cruelty will pour in from the same crowd that considers it compassionate to sterilize teenagers. None of it changes the fundamental reality. When future generations examine this chapter, they won’t wonder why the Trump administration acted. They’ll wonder why it took so long. And why anyone ever thought experimenting on children with taxpayer money was defensible in the first place.

Key Takeaways

• Trump’s CMS rule ends Medicaid and CHIP funding for pediatric sex-change procedures.
• Multiple European nations independently restricted these same interventions over weak evidence.
• Fewer than 1% of minors received surgical procedures — the outrage far exceeds the data.
• Mental health services remain untouched; only irreversible physical interventions are blocked.

Sources: The Post Millennial, The Hill